Posted 10 hours ago
Proposed by Scientific Boston
Sponsored Content originally posted by Fastco Works on Fast Company
Everyone knows that radiation kills tumors. Yet traditional radiation can also cause serious side effects. What if a treatment could minimize these side effects? TheraSphere Y-90 glass microspheres do just that. This minimally invasive form of radiation targets the blood stream that normally supplies tumors. “We’ve basically taken one of cancer’s greatest strengths and used it against it,” says Peter Pattison, president of interventional oncology, peripheral interventions, at Boston Scientific, the Marlborough-based medical device company, Massachusetts, which manufactures TheraSphere.
This remarkable innovation received FDA approval for the treatment of HCC earlier this year. Today, the Boston Scientific team is studying how TheraSphere could be used to treat other types of tumors.
View original content here
Boston Scientific is a global medical device developer, manufacturer and marketer whose products are used in a wide range of interventional medical specialties.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a wide range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and log on to Twitter and Facebook.
More Scientific Boston